Identification and antibiotic susceptibility of coagulase negative staphylococci isolated in corneal/external infections

British Journal of Ophthalmology

Volumn 83, Issue 7, 1999, Pages 771-773

  Pinna, Antonio ^a   Zanetti, Stefania ^a   Sotgiu, Mario ^a   Sechi, Leonardo A ^a   Fadda, Giovanni ^b   Carta, Francesco ^a  

^a UNIVERSITY OF SASSARI   (Italy)

^b CATHOLIC UNIVERSITY   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CIPROFLOXACIN; ERYTHROMYCIN; GENTAMICIN; PENICILLIN G; TEICOPLANIN; TETRACYCLINE;

AGAR GEL DIFFUSION; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM IDENTIFICATION; BLEPHARITIS; CLINICAL ARTICLE; COAGULASE NEGATIVE STAPHYLOCOCCUS; CONJUNCTIVITIS; CONTROLLED STUDY; EYE INFECTION; HUMAN; KERATITIS; MINIMUM INHIBITORY CONCENTRATION; MULTIDRUG RESISTANCE; NONHUMAN; PRIORITY JOURNAL; RETROSPECTIVE STUDY; STAPHYLOCOCCUS EPIDERMIDIS; STAPHYLOCOCCUS LUGDUNENSIS; STAPHYLOCOCCUS SIMULANS;

EID: 0032810696     PISSN: 00071161     EISSN: None     Source Type: Journal    
DOI: 10.1136/bjo.83.7.771     Document Type: Article

References (18)

1. McCulley JP, Dougherty JM, Denau DG. Classification of chronic blepharitis. Ophthalmology 1982;89:1173-80.
2. Dougherty JM, McCulley JP. Comparative bacteriology of chronic blepharitis. Br J Ophthalmol 1984;68:524-8.
3. McCulley JP, Dougherty JM. Bacterial aspects of chronic blepharitis. Trans Ophthalmol Soc UK 1986;105:314-8.
4. Soukiasian SH, Baum J. Bacterial conjunctivitis. In: Krachmer JH, Mannis MJ, Holland EJ, eds. Cornea. St Louis, Mosby-Year Book, 1996; vol 2: chap 63.
5. Leibowitz HM. Antibacterial effectiveness of ciprofloxacin 0.3% ophthalmic solution in the treatment of bacterial conjunctivitis. Am J Ophthalmol 1991;112:29S-33S.
6. O'Brien TP, Maguire MG, Fink NE, et al. Efficacy of ofloxacin vs cefazolin and tobramycin in the therapy for bacterial keratitis. Arch Ophthalmol 1995;113:1257-65.
7. Hyndiuk RA, Eiferman RA, Caldwell DR, et al. Comparison of ciprofloxacin ophthalmic solution 0.3% to fortified tobramycin-cefazolin in treating bacterial corneal ulcers. Ophthalmology 1996;103:1854-63.
8. Kloos WE, Bannerman TL. Staphylococcus and Micrococcus. In: Murray PR, Baron EJ, Pfaller MA, Tenover FC, Yolken RH, eds. Manual of clinical microbiology. 6th ed. Washington, DC: American Society for Microbiology, 1995: chap 22.
9. Jones DB, Liesegang TJ, Robinson NM. Cumitech 13: laboratory diagnosis of ocular infections. Washington, DC: American Society for Microbiology, 1981.
10. National Committee for Clinical Laboratory Standards. Performance standards for antimicrobial disk susceptibility tests. Approved standards M2-A5. Villanova, PA: National Committee for Clinical Laboratory Standards, 1993.
11. National Committee for Clinical Laboratory Standards. Methods far dilution antimicrobial susceptibility tests for bacteria that grow aerobically. Approved standard M7-A4. Villanova, PA: National Committee for Clinical Laboratory Standards, 1997.
12. Archer GL, Climo MW. Antimicrobial susceptibility of coagulase-negative staphylococci. Antimicrob Agents Chemother 1994;38:2231-7.
13. Ieven M, Verhoeven J, Pattyn SR, et al. Rapid and economical method for identification of clinically significant coagulase-negative staphylococci, J Clin Microbiol 1995;33: 1060-3.
14. Kattan HM, Flynn HW, Pfugfelder SC, et al. Nosocomial endophthalmitis survey: current incidence of infection after surgery. Ophthalmology 1991;98:227-38.
15. Speaker MG, Milch FA, Shah MK, et al. Role of external bacterial flora in the pathogenesis of acute postoperative endophthalmitis. Ophthalmology 1991;98:639-49.
16. Neu HC. Microbiologic aspects of fluoroquinolones. Am J Ophthalmol 1991;112:15S-24S.
17. Degener JE, Heck MEOC, van Leeuwen WJ, et al. Nosocomial infection by Staphylococcus haemolyticus and typing methods for epidemiological study. J Clin Microbiol 1994;32:2260-5.
18. Snyder ME, Katz HR. Ciprofloxacin-resistant bacterial keratitis. Am J Ophthalmol 1992;114:336-8.